Your browser doesn't support javascript.
loading
MEF2 and the tumorigenic process, hic sunt leones.
Di Giorgio, Eros; Hancock, Wayne W; Brancolini, Claudio.
Afiliação
  • Di Giorgio E; Department of Medicine, Università degli Studi di Udine, P.le Kolbe 4, 33100 Udine, Italy.
  • Hancock WW; Division of Transplant Immunology, Department of Pathology and Laboratory Medicine, Biesecker Center for Pediatric Liver Diseases, Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Brancolini C; Department of Medicine, Università degli Studi di Udine, P.le Kolbe 4, 33100 Udine, Italy. Electronic address: claudio.brancolini@uniud.it.
Biochim Biophys Acta Rev Cancer ; 1870(2): 261-273, 2018 12.
Article em En | MEDLINE | ID: mdl-29879430
ABSTRACT
While MEF2 transcription factors are well known to cooperate in orchestrating cell fate and adaptive responses during development and adult life, additional studies over the last decade have identified a wide spectrum of genetic alterations of MEF2 in different cancers. The consequences of these alterations, including triggering and maintaining the tumorigenic process, are not entirely clear. A deeper knowledge of the molecular pathways that regulate MEF2 expression and function, as well as the nature and consequences of MEF2 mutations are necessary to fully understand the many roles of MEF2 in malignant cells. This review discusses the current knowledge of MEF2 transcription factors in cancer.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinogênese / Fatores de Transcrição MEF2 / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Biochim Biophys Acta Rev Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinogênese / Fatores de Transcrição MEF2 / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Biochim Biophys Acta Rev Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália